InvestorsHub Logo
Followers 32
Posts 5818
Boards Moderated 0
Alias Born 05/23/2006

Re: None

Thursday, 05/18/2017 7:35:28 AM

Thursday, May 18, 2017 7:35:28 AM

Post# of 346228
good article on pd1 etc...

http://www.oncotherapynetwork.com/cancer-and-genetics/pd-l1-predictive-biomarker-anti-pd-1anti-pd-l1-therapies-non-small-cell-lung-cancer

key takeaway from art..

"It may be that multiple companion predictive biomarkers (an immune panel of sorts) measuring components in the PD-1/PD-L1 axis, TILs, and various stimulatory molecules, will be required to predict response to immune therapies. While the idea of a companion predictive biomarker for immune therapies remains compelling, one must recognize the inherent difficulties in attempting to identify such a marker."

As for the sunrise data, the mos for TOC 0 is a good start .... but big bucks are needed to flush it out ...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News